No. 19-1058

Hospira, Inc. v. Eli Lilly and Company

Lower Court: Federal Circuit
Docketed: 2020-02-26
Status: Denied
Type: Paid
Amici (1) Experienced Counsel
Tags: claim-drafting claim-narrowing doctrine-of-equivalents literal-infringement patent-claim-interpretation patent-claims patent-prosecution-estoppel patent-prosecution-history-estoppel patent-scope prior-art-rejection tangential-relation tangential-relation-exception
Key Terms:
Patent TradeSecret JusticiabilityDoctri
Latest Conference: 2020-06-11
Related Cases: 19-1061 (Vide)
Question Presented (AI Summary)

Whether a patentee may recapture subject matter via the doctrine of equivalents under the 'tangential relation' exception

Question Presented (OCR Extract)

QUESTION PRESENTED This Court has long recognized the doctrine of prosecution history estoppel, which provides that when a patentee narrows a claim during patent prosecution for a “substantial reason related to patentability,” “the court should presume that the patentee surrendered all subject matter between the broader and the narrower language,” and therefore may not reclaim that subject matter under the doctrine of equivalents. Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 585 U.S. 722, 740 (2002). In Festo, this Court held that “[t]here are some cases, however, where the amendment cannot reasonably be viewed as surrendering a particular equivalent.” Id. at 740. One such scenario arises when “the rationale underlying the amendment may bear no more than a tangential relation to the equivalent in question.” Jd. The Court then went on to hold that “It]he patentee must show that at the time of the amendment one skilled in the art could not reasonably be expected to have drafted a claim that would have literally encompassed the alleged equivalent.” Id. at 7Al. The question presented is: Whether a patentee may recapture subject matter via the doctrine of equivalents under the “tangential relation” exception by arguing that it surrendered more than it needed to during prosecution to avoid a prior art rejection, even if a claim could reasonably have been drafted that would literally have encompassed the alleged equivalent.

Docket Entries

2020-06-15
Petition DENIED.
2020-05-26
DISTRIBUTED for Conference of 6/11/2020.
2020-05-26
Reply of petitioner Hospira, Inc. filed. (Distributed)
2020-05-01
Motion of petitioner to delay distribution of the petition for a writ of certiorari under Rule 15.5 from May 12, 2020 to May 26, 2020, submitted to The Clerk.
2020-05-01
Motion to delay distribution of the petition for a writ certiorari until May 26, 2020, granted.
2020-03-26
Brief amicus curiae of America's Health Insurance Plans filed.
2020-03-11
Motion to extend the time to file a response is granted and the time is extended to and including April 27, 2020.
2020-03-10
Motion to extend the time to file a response from March 27, 2020 to April 27, 2020, submitted to The Clerk.
2020-02-24
Petition for a writ of certiorari filed. (Response due March 27, 2020)
2020-01-28
Application (19A841) granted by The Chief Justice extending the time to file until February 24, 2020.
2020-01-24
Application (19A841) to extend the time to file a petition for a writ of certiorari from February 6, 2020 to February 24, 2020, submitted to The Chief Justice.

Attorneys

America's Health Insurance Plans
Anna-Rose MathiesonCalifornia Appellate Law Group LLP, Amicus
Eli Lilly and Company
Adam Lawrence PerlmanLatham& Watkins LLP, Respondent
Hospira, Inc.
Adam G. UnikowskyJenner & Block LLP, Petitioner
R Street Institute
Charles DuanR Street Institute, Amicus